Elysium Health, a health-oriented startup, has effectively positioned itself to take up the demanding role of delivering clinically tested supplements to the public. Since the company relies heavily on the work of researchers, Elysium Health has sought to align its operations with award-winning, world-renowned scientists. The company also has partnerships with major research institutions, including Cambridge, Oxford, and Harvard.
Established in 2014 by Dr. Leonard Guarente, the Director of the Glenn Laboratories for the Science of Aging at MIT, Elysium Health is committed to bringing safe and effective products to the public. The first and only product Elysium Health has delivered in the market is Basis, a daily supplement that seeks to support your cellular health.
Basis replenishes your cells with nicotinamide adenine dinucleotide—shortened to NAD+. The coenzyme plays a critical role in your body, specifically in cellular biological processes. As age advances, production of NAD+ can decline. The decline can then affect the major cellular processes that depend on sufficient supply of NAD+. Some of these processes include DNA maintenance, energy creation, and circadian rhythm regulation.
The supplement Basis, therefore, is designed to sustain NAD+ levels. Basis has taken a significant amount of time and resources in terms of research and development. The supplement has been clinically proven to work. World-class scientists sit on the company’s board. Following its vision of making the product available to everybody, Elysium Health offers Basis in several subscription plans on the company’s website. The monthly subscription plan is available at $50. However, the most used method by many people is the $270 plan that is renewable after every six months.